FDA Orange Book
Generic for Xyrem
Xyrem contains sodium oxybate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Xyrem is sodium oxybate. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AA.
Run it in Rivvi
Map Xyrem and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Xyrem products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| solution, oral | 0.5GM/ML | Marketed (Rx) | AA | 2 | AA |
NDA 021196, held by JAZZ PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic sodium oxybate
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| AMNEAL PHARMACEUTICALS LLC | 203631 | AA (A-rated, therapeutically equivalent) | September 10, 2025 | 0.5GM/ML |
| ASCENT PHARMACEUTICALS INC | 210523 | AA (A-rated, therapeutically equivalent) | November 5, 2025 | 0.5GM/ML |
Xyrem patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 10213400 | March 15, 2033 | Method of use | U-2499 | 021196 |
| 9486426 | March 15, 2033 | Method of use | U-1532 | 021196 |
| 9050302 | March 15, 2033 | Method of use | U-1532 | 021196 |
| 8772306 | March 15, 2033 | Method of use | U-1532 | 021196 |
| 11986446 | March 15, 2033 | Method of use | U-3324 | 021196 |
| 10864181 | March 15, 2033 | Method of use | U-1532 | 021196 |
| 11253494 | March 15, 2033 | Method of use | U-3323 | 021196 |
| 11253494 | March 15, 2033 | Method of use | U-3324 | 021196 |
| 8772306*PED | September 15, 2033 | Method of use | None | 021196 |
| 9486426*PED | September 15, 2033 | Method of use | None | 021196 |
| 9050302*PED | September 15, 2033 | Method of use | None | 021196 |
| 11253494*PED | September 15, 2033 | Method of use | None | 021196 |
| 10213400*PED | September 15, 2033 | Method of use | None | 021196 |
| 10864181*PED | September 15, 2033 | Method of use | None | 021196 |
Xyrem exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| ODE-231 | Orphan drug exclusivity | October 26, 2025 | 021196 |
| PED | Pediatric exclusivity | April 26, 2026 | 021196 |
Xyrem NDC codes
Questions
Is there a generic for Xyrem?
Yes. The generic name for Xyrem is sodium oxybate. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AA.
What is the generic name for Xyrem?
The active ingredient in Xyrem is sodium oxybate, per the FDA Orange Book.
When does the Xyrem patent expire?
The last patent listed for Xyrem in the Orange Book expires September 15, 2033. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Xyrem and Sodium Oxybate
- What is Xyrem used for?FDA label uses
- Is Xyrem a controlled substance?Schedule III
- What is Sodium Oxybate used for?FDA label uses
- Is Sodium Oxybate a controlled substance?Schedule III
- Generic for LumryzFDA Orange Book
- Central Nervous System Depressants listFDA drug class
- NDC 68727-100Xyrem NDC record
- Schedule III drugs listDEA schedule